Susquehanna International Group, LLP F Star Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$4.09 - $6.86 $211,330 - $354,456	-51,670 Reduced 48.41%	55,066 $348,000
Q3 2022 Nov 14, 2022	SELL	$5.41 - $6.74 $222,881 - $277,674	-41,198 Reduced 27.85%	106,736 $546,000
Q2 2022 Aug 15, 2022	BUY	$2.18 - $6.39 $322,496 - $945,298	147,934 New	147,934 $926,000
Q1 2022 May 16, 2022	SELL	$2.77 - $5.36 $39,475 - $76,385	-14,251 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.71 - $7.38 $67,122 - $105,172	14,251 New	14,251 $72,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.